Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06784791 |
| Title | Preoperative Amivantamab or Amivantamab and Carboplatin/pemetrexed Treatment in Patients with Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR) (NEOpredict-EGF) |
| Acronym | NEOpredict-EGF |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Hospital, Essen |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Jessa Ziekenhuis, Department of Pneumology | RECRUITING | Hasselt | 3500 | Belgium | Details | |
| Thoraxklinik Heidelberg gGmbH, Studienzentrum Thoraxonkologie | RECRUITING | Heidelberg | Baden-Württemberg | 69126 | Germany | Details |
| West German Cancer Center, Department of Medical Oncology, University Hospital Essen | RECRUITING | Essen | 45147 | Germany | Details |